Search Result "treatment-naive."
Longitudinal Assessment of Virological Failure and Antiretroviral DrugResistance among Treatment-naive Subjects Living with HIV
Journal: Current HIV Research
Volume: 21 Issue: 3 Year: 2023 Page: 213-219
Author(s): Chaiana Esmeraldino Mendes Marcon,Aline Daiane Schlindwein
Response to HAART in Treatment-Naive HIV-Infected Patients with a Prior Diagnosis of Tuberculosis or other Opportunistic Infections
Journal: Current HIV Research
Volume: 9 Issue: 4 Year: 2011 Page: 229-236
Author(s): Fernando Dronda, Paz Sobrino-Vegas, Beatriz Hernandez-Novoa, Ana M. Caro-Murillo, Marta Montero, Jose A. Iribarren, Jesus Sanz, Maria del Mar Alonso, Pablo Labarga, Enrique Bernal, Santiago Moreno1, CoRIS
Baseline Levels of Interleukine-6, Tumor-Necrosis Factor-Alpha and C-Reactive Protein in Treatment Naive Human Immunodeficiency Virus Infected Patients-A Study from a Tertiary-Care Hospital in Eastern India
Journal: Current Biomarkers (Discontinued)
Volume: 6 Issue: 2 Year: 2016 Page: 124-132
Author(s): Anindita Debnath,Madhuchhanda Mandal,Sayantani Choudhuri,Malay K. Saha,Subhasish Kamal Guha
Integrase Strand Transfer Inhibitor (INSTI) Genotypic Resistance Analysisin Treatment-Naive, INSTI Free Antiretroviral-Experienced andINSTI-Experienced Turkish Patients Infected with HIV-1
Journal: Current HIV Research
Volume: 20 Issue: 2 Year: 2022 Page: 184-192
Author(s): Figen Sarigul Yildirim
Sex and Gender Differences in Rilpivirine based ART - Data from the HIVCENTER Frankfurt
Journal: Current HIV Research
Volume: 17 Issue: 5 Year: 2019 Page: 368-374
Author(s): G. Schüttfort,K. Philipp,P. de Leuw,E. Herrmann,G. Kann,P. Khaykin,C. Stephan,T. Wolf,A. Haberl
Outcomes of Methadone Maintenance Therapy Combined with Rilpivirine/Efavirenz in Treatment-Naive HIV-Infected Patients
Journal: Current HIV Research
Volume: 19 Issue: 4 Year: 2021 Page: 368-376
Author(s): Shizhen Huang,Cuixian Yang,Jiaying Xin,Ronghui Xie,Xinping Yang,Ruimin Zhang,Xia Li,Bo Zhang,Suyun Lei,Lizhu Hong,Xingqi Dong,Huiqin Li
Vitamin D Assessment Over 48 Weeks in Treatment-Naive HIV Individuals Starting Lopinavir/Ritonavir Monotherapy
Journal: Current HIV Research
Volume: 19 Issue: 1 Year: 2021 Page: 61-72
Author(s): Rustin D. Crutchley,David M. Jacobs,Joseph Gathe,Carl Mayberry,Nataliya Bulayeva,Kevin P. Rosenblatt,Kevin W. Garey
The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor
Journal: Current Clinical Pharmacology
Volume: 11 Issue: 2 Year: 2016 Page: 88-94
Author(s): Harmanjit Singh,Mandeep Kaur,Ashish K. Kakkar,Harish Kumar
Impact of Lopinavir/Ritonavir and Efavirenz-Based Antiretroviral Therapy on the Lipid Profile of Chinese HIV/AIDS Treatment-Naïve Patients in Beijing: A Retrospective Study
Journal: Current HIV Research
Volume: 17 Issue: 5 Year: 2019 Page: 324-334
Author(s): Lili Dai,An Liu,Hongwei Zhang,Hao Wu,Tong Zhang,Bin Su,Ying Shao,Jianwei Li,Jiangzhu Ye,Sarah Robbins Scott,Supriya D. Mahajan,Stanley A Schwartz,Hongwei Yu,Lijun Sun
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
Journal: Current HIV Research
Volume: 14 Issue: 1 Year: 2016 Page: 61-70
Author(s): Leonardo Calza,Eleonora Magistrelli,Ilaria Danese,Vincenzo Colangeli,Marco Borderi,Isabella Bon,Maria Carla Re,Rita Mancini,Matteo Conti,Roberto Motta,Pierluigi Viale